Cynata Therapeutics and Japan’s Regience K.K. in stem cell alliance – Proactive Investors Australia
|
Cynata Therapeutics and Japan’s Regience K.K. in stem cell alliance
Proactive Investors Australia The Cymerus stem cell technology provides a source of MSCs that is independent of donor limitations and provides a potential “off-the-shelf” stem cell platform for therapeutic product use, with a pharmaceutical business model and economies of scale. Cynata Enters Agreement for Strategic Alliance in Japanirasia.com (press release) |
|
Story on stem–cell treatment appreciated
Sentinel-Tribune Thank you so much to the Sentinel-Tribune and Debbie Rogers for the wonderfully informative article about our children, Rich and Julie Amos and Julie’s stem–cell treatment (using her own stem–cells) to stop her quickly-progressing MS. Julie is … |
|
Research shows stem cell infusion could be effective for most common type of heart failure
Science Codex Marbán, an international leader in cardiac stem cell research, led the Cedars-Sinai team that completed the world’s first cardiac stem cell infusion in 2009. Results from that clinical trial, published in The Lancet, showed that stem cells could … |